Iomervu (Iomeprol)

Iomervu (iomeprol) is a radiographic contrast agent used for Intra-arterial and Intravenous Procedures.
Intra-arterial Procedures:

• Cerebral arteriography, including intra-arterial digital
• subtraction angiography (IA-DSA), in adult and pediatric patients
• Visceral and peripheral arteriography and aortography, including IA-DSA, in adult and pediatric patients
• Coronary arteriography and cardiac ventriculography in adults
• Radiographic evaluation of cardiac chambers and related arteries in pediatric patients

Intravenous Procedures:

• Computed tomography (CT) of the head and body in adults and pediatric patients
• CT angiography of intracranial, visceral, and lower extremity arteries in adults and pediatric patients
• Coronary CT angiography in adults and pediatric patients
• CT urography in adults and pediatric patients

Note: Specific concentrations are generally recommended for each type of imaging procedure.

Recommended Dosage: The recommended dosage of Iomervu is for intra-arterial or intravenous use only and must not be administered intrathecally. Specific concentrations of this drug are recommended for each type of imaging procedure.
Individualize the dose carefully. Adjust volume, concentration, and injection rate within specified ranges. Consider factors like age, weight, vessel size, and blood flow. Account for the disease, pathology, and examination area. Hydrate patients before and after use. Ensure safe administration by using appropriate equipment and techniques.

• Treatment with Iomervu must be used with caution intrathecally as improper administration may cause severe neurological complications, including seizures or paralysis. Only qualified professionals should perform this procedure under strict guidelines.
• Hypersensitivity reactions, including anaphylaxis, may occur with this medicine. Monitor patients for early symptoms such as rash, difficulty breathing, or swelling. Emergency medical intervention must be available during administration.
• This therapeutic drug can cause acute kidney injury, especially in patients with pre-existing renal impairment. Monitor kidney function before and after the use of this medicine. Ensure adequate hydration to reduce the risk of nephrotoxicity.
• Cardiovascular reactions, including arrhythmias or hypotension, may occur. Patients with pre-existing heart conditions require close monitoring during and after Iomervu administration to manage potential adverse effects effectively.
• Iomervu may increase the risk of thromboembolic events such as deep vein thrombosis or pulmonary embolism. Use caution in patients with clotting disorders and closely monitor for signs of thrombosis.
• Patients with hyperthyroidism are at risk of thyroid storm when exposed to iodinated contrast agents like Iomervu. Monitor thyroid function and use the agent cautiously in such individuals.
• This treatment should only be used during pregnancy if absolutely necessary, as it may pose risks to the developing fetus. Discuss potential risks and benefits with the patient before use.
• Limited data suggest Iomervu may pass into breast milk. Consider temporarily discontinuing breastfeeding or assessing the risk-benefit ratio before administering the agent to lactating mothers.

What documents are required to import IOMERVU to India?

IOMERVU (iomeprol) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is IOMERVU available in India?

IOMERVU (iomeprol injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Iomervu in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

IOMERVU can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of IOMERVU (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Iomervu injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source IOMERVU (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Iomervu®?

Iomeprol is a Generic Name for the trade name drug Iomervu®.

What is the Manufacturer's Name of Iomervu®?

Iomervu® is manufactured by BIPSO (Bracco Imaging Pharmaceutical Sterile Operations) GmbH.

Is Iomervu® approved by the FDA?

Yes, Iomervu® is approved by the FDA. Date of first approval: 27 November 2024.

What is the dosage and form of Iomervu® supplied?

Iomervu is supplied as Injection: 250 mg Iodine/mL, 300 mg Iodine/mL, 350 mg Iodine/mL, and 400 mg Iodine/mL in single-dose vials or bottles for intra-arterial or intravenous use.

What are the most common side effects of Iomervu® injection?

The most common side effects of Iomervu® are nausea, feeling hot, headache, chest pain, back pain, and vomiting.

How much does Iomervu® injection cost in India?
Prices of Iomervu 250 mg Iodine/mL, 300 mg Iodine/mL, 350 mg Iodine/mL, and 400 mg Iodine/mL in single-dose vials or bottles may fluctuate over time because of market dynamics and regulatory changes. To get the most recent details on Iomervu injection cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Iomervu® injection be available in SAARC countries?

Apart from Gulf countries, Iomervu® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Iomervu® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Iomervu® injections online in India?

Yes, one can buy Iomervu online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the legal supply of Iomervu® injections through legal channels.

What are the storage conditions of Iomervu® injections?

Store the vials or bottles at 20°C to 25°C (68°F to 77°F). Keep in original carton with the cover closed to protect from light. Do not freeze.